ISS V: Immuno-Oncology: New Standard of Care as Monotherapy and in Combination for Gynecologic Cancers

MTCC: 701

This symposium is supported by Merck.

Bradley Monk, MD, Phoenix – Biltmore Cancer Center, Phoenix, AZ

Krishnansu Tewari, MD, University of California Irvine Medical Center, Orange, CA
Ramez Eskander, MD, UCSD Moore Cancer Center, La Jolla, CA
Rebecca Arend, MD, University of Alabama at Birmingham, Birmingham, AL

Forum for the exchange of the latest scientific information and knowledge in gynecologic cancers. Sharing current and emerging therapies including providing up-to-date IO therapies. The session will touch on scientific controversies and physician’s experiences from the clinical trial setting to daily practice.